Use of antisense oligonucleotides to treat rare diseases By Rosie Davies   A rare disease is a disorder that affects less than 5 in 10,000 of the general population. Although individually rare, as a whole, there are up to 8000 known rare diseases, affecting approximately 3.5 million people in the UKand impacts tens of millions of individuals globally. Moreover, the number of newly published rare diseases is increasing at a

We need writers to help us add content to our blog. If you’re a keen writer, interested in a career in science communication, or just passionate about translational medicine and want to tell the world, we want to hear from you! We need volunteer writers to help us develop content for our blog. Perhaps you want to get some publicity about your fascinating research, want to tell the science community

by Rosie Davies …   I’m very excited to launch our first blog post for Apollo London. It has been a fairly hectic year setting up Apollo London, from our first meeting to discuss the conception in January 2018, our launch event in October 2018 and a smattering of events throughout the academic year. I’d like to take this first blog post to thank everyone who has supported us, including

This blog is in development and we are currently waiting for the next post to be written. If you’d like to help us fill the blog with interesting news and opinions about translational medicine, then please get in touch!